BCL2 and cardiomyopathy: In fact, increased expression of anti-apoptotic proteins in cardiomyocytes, such as Bcl-2, and increased apoptosis in general is a consistent feature of end-stage heart failure [60] and correlates with the clinical severity of cardiomyopathy [5].